Cell Therapeutics Named in Securities Fraud Suits
Seattle law firm Keller Rohrback LLP has filed a securities fraud case in U.S. District Court in Seattle against Cell Therapeutics Inc., a Seattle-based biotech company. It's one of several securities lawsuits that have been filed against the company recently. The Keller Rohrback suit alleges that the company and certain officers and directors issued a series of false and misleading statements concerning the company's cancer treatment products, which caused the company's shares to trade at inflated prices between June 7, 2004, and March 4, 2005, according to the court documents.
Puget Sound Business Journal (http://www.bizjournals.com/seattle/stories/2005/03/21/daily28.html)